Antiviral treatment is prescribed for HBeAg-negative hepatitis patients with viral DNA levels >10,000 copies/mL and either a twofold increase in ALT and/or histologic activity (>A2) or fibrosis (>F2) [24,25]. Here, GPT is linked to hepatitis A virus infection.